DUBLIN--(BUSINESS WIRE)--The "Microbiome Sample Preparation Technology Market by Product, Workflow, by Disease Type, Application, by End User, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
The microbiome sample preparation technology market size is estimated to be USD 295.8 million in 2022 and is expected to witness a CAGR of 6.54% during the forecast period 2023-2033. Rising investment for microbiome research, development of microbiome-based therapies, along with lowering sequencing costs, and continuous decline in the price of genomic testing are factors contributing to the market growth. Additionally, increasing use of instruments and consumables in the North America is expected to propel the market growth. However, lack of thorough research, regulatory regulations are expected to hinder the growth.
Rising investment for microbiome research is predicted to fuel the market growth. The demand for microbiome sample preparation technology from academic and research institutions is projected to increase as grants and funding programmes for microbiome-based research are expanded. Five academic institutions, including Harvard School of Public Health, Columbia University Health Sciences, Graduate School of Public Health and Health Policy, and New York University School of Medicine, were awarded grants from the National Cancer Institute in 2022. The grant was worth between USD 387,513 and USD 717,936.
Development of microbiome-based therapies is projected to support the market growth. The demand for microbiome sampling technologies is directly impacted by treatments based on the microbiome. In recent years, it has been found that the chemicals made by the gut microbial community that influence cellular and organismal processes have a major impact on host physiology since they act as an efficient channel of communication in host-microbe interactions. For instance, Digbi Health, a startup that provides care for people with genetic and gut microbiome issues, took part in Novo Nordisk's Global Prevention Accelerator Program in August 2022. Selected participants are expected to receive investment support from Novo Nordisk as a result of the initiative, which was created to invite potential start-ups to submit their solutions.
Segmentation: Microbiome Sample Preparation Technology Market Report 2022 - 2033
Product (Revenue, USD Million)
- Consumables
- Instruments
Workflow (Revenue, USD Million)
- Quality Control
- Sample Extraction
- Library Quantification
- Fragmentation
- Pooling
- Target Enrichment
- Library Preparation
- Sample Quantification
Disease Type (Revenue, USD Million)
- Gastrointestinal Disorders
- Autoimmune Disorders
- Cancer
- Others
Application (Revenue, USD Million)
- RNA Sequencing
- DNA Sequencing
- Single Cell Sequencing
- Methylation Sequencing
- Whole-Genome Sequencing
- Metagenomics
- Others
End user (Revenue, USD Million)
- Diagnostic Labs
- Pharmaceutical & Biotechnology
- Others
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Microbiome Sample Preparation Technology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Microbiome Sample Preparation Technology Market
7. Market Analysis by Product
8. Market Analysis by Workflow
9. Market Analysis by Disease Type
10. Market Analysis by Application
11. Market Analysis by End user
12. Regional Market Analysis
13. North America Microbiome Sample Preparation Technology Market
14. Europe Microbiome Sample Preparation Technology Market
15. Asia Pacific Microbiome Sample Preparation Technology Market
16. Latin America Microbiome Sample Preparation Technology Market
17. MEA Microbiome Sample Preparation Technology Market
18. Competitor Analysis
19. Company Profiles
20. Conclusion & Recommendations
Companies Mentioned
- QIAGEN
- BGI
- Bio-Rad Laboratories Inc.
- Perkin Elmer Inc.
- Agilent Technologies Inc.
- Illumina Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation.
For more information about this report visit https://www.researchandmarkets.com/r/38z34a
